Table 1.
Baseline Characteristics
| Group I (Dexmedetomidine) | Group II (Propofol) | P Value | |||||
|---|---|---|---|---|---|---|---|
| Age, years (range) | 73.2 (50–94) | 67.5 (22–93) | 0.064 | ||||
| Gender, n (%) | Male: 32 (57%) Female: 24 (43%) |
Male: 28 (51%) Female: 27 (49%) |
0.570 | ||||
| Creatinine clearance, mL/min, median (IQR) | 36.1 (20.5–66.8) | 48.8 (23.0–58.7) | 0.336 | ||||
| APACHE II score, median (IQR) | 18.0 (14.5–24.0) | 20.0 (16.0–25.0) | 0.423 | ||||
| Child–Pugh score, n (%) | A | B | C | A | B | C | 0.705 |
| 28 (50%) | 28 (50%) | 0 (0%) | 29 (53%) | 25 (45%) | 1 (2%) | ||
| CAM-ICU documentation compliance ratio, median (IQR) | 0.92 (0.50–1.00) | 0.67 (0.43–1.00) | 0.100 | ||||
APACHE = Acute Physiologic Assessment and Chronic Health Evaluation; CAM-ICU = Confusion Assessment Method in the Intensive Care Unit; IQR = interquartile range.